Viral Clearance Market Trends

Growth Drivers

Growing Prevalence of Infectious Diseases to Boost the Market Growth - Based on the report provided by the World Health Organization (WHO), it was noticed that around 50,000 people die every day owing to some infectious diseases worldwide.
Infectious diseases are caused by various fungi, bacteria, and viruses and can be life-threatening sometimes. Diseases and disorders associated with infections are triggered by certain organisms that require early diagnosis so that they can be healed before spreading to multiple parts of the body. Viral clearance becomes useful since it removes viral contamination utilizing membranes or chromatography.
Increasing Cases of Chronic Disease - According to the Centers for Disease Control and Prevention, it was noticed that 6 in 10 Americans have at least 1 chronic disease.
Rising Demand for Viral Clearance in Non-Communicable Diseases - World Health Organization (WHO) stated that non-communicable diseases cause nearly 17.9 million people per year.
Significant Increment in the Number of Viral Fevers - For instance, more than 150 million dengue virus infections are diagnosed every year across the globe.

Challenges

Long-Lasting Development Procedure for Drug Discovery
Lack of the Requisite Medical Workforce
Requirement for Higher Initial Investment

Viral Clearance Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	19.2%
Base Year Market Size (2024)	USD 793.57 million
Forecast Year Market Size (2037)	USD 8.06 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of viral clearance is estimated at USD 916.73 million.

The viral clearance market size was over USD 793.57 million in 2024 and is set to cross USD 8.06 billion by the end of 2037, growing at more than 19.2% CAGR during the forecast period i.e., between 2025-2037. Increasing cases of chronic disease and a significant increment in the number of viral fevers will boost the market growth.

North America industry is projected to account for largest revenue share by 2037, backed by presence of major key players and the escalation in number of drug approval in the region.

The major players in the market include Texcell Inc., Merck KGaA, Charles River Laboratories, Inc., Sartorius AG, SGS AG, Syngene International Limited, Lonza AG, Kedrion S. p. A., and others. .

Viral Clearance Market Trends